antiviral therapy - general principles

36
Antiviral therapy - General Principles JIANER LONG, Ph.D. Lab of Medical Microbiology, Department of Medical Microbiology and Parasitology, Shang Medical College of Fudan University, 138 Yixueyuan R., Shanghai 200032, PR China Email: [email protected]; Tel.: +86-21-54237867

Upload: others

Post on 01-Aug-2022

3 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Antiviral therapy - General Principles

Antiviral therapy - General Principles

JIANER LONG, Ph.D.

Lab of Medical Microbiology, Department of Medical Microbiology and Parasitology, Shang Medical College of Fudan University,

138 Yixueyuan R., Shanghai 200032, PR ChinaEmail: [email protected]; Tel.: +86-21-54237867

Page 2: Antiviral therapy - General Principles
Page 3: Antiviral therapy - General Principles

1. Virus replication is dependent to the host cellsAntiviral must be selective for viral enzyme orprotein, or inhibit virus-specific process

2. Usually antivirals inhibit replication, don’t kill virus

Reliance on host immune response for ultimate virus elimination

3. High error rate of viral replicationRapid development of drug resistanceNeed to suppress virus replication rapidly and efficiently

Antiviral Therapy – important notes

Page 4: Antiviral therapy - General Principles

VIRAL LIFE

CYCLE

ATTACHMENT

PENETRATION HOSTFUNCTIONS

ASSEMBLY(MATURATION)

Transcription

REPLICATION

RELEASE

UNCOATING

Translation

MULTIPLICATION

Click after each step to view process

Page 5: Antiviral therapy - General Principles
Page 6: Antiviral therapy - General Principles
Page 7: Antiviral therapy - General Principles
Page 8: Antiviral therapy - General Principles

Example: Fuzeon – anti-retroviral drug(Inhibition of gp41 mediated infusion)

Attachment

Fuzeon(enfuvirtide)

Page 9: Antiviral therapy - General Principles
Page 10: Antiviral therapy - General Principles
Page 11: Antiviral therapy - General Principles
Page 12: Antiviral therapy - General Principles

The entry of influenza virus into cells and amatadine

M2, this viral protein forms a channel in the membrane that actively pumps protons from the endosome into the interior of the virion. These protons lower the pH in the interior of the virion, releasing the viral RNAs from M1. In this way the RNAs can enter the nucleus.

Page 13: Antiviral therapy - General Principles

Amantadine Hydrochloride

Pleconaril

Page 14: Antiviral therapy - General Principles
Page 15: Antiviral therapy - General Principles
Page 16: Antiviral therapy - General Principles
Page 17: Antiviral therapy - General Principles

deoxyadenosine analogues Didanosine (ddI)(HIV) Vidarabine (chemotherapy)

deoxycytidine analogues Cytarabine (chemotherapy) Emtricitabine (FTC)(HIV) Lamivudine (3TC)(HIV, hepatitis B) Zalcitabine (ddC)(HIV)

deoxyguanosine analogues Abacavir (HIV) Entecavir (hepatitis B)

(deoxy-)thymidine analogues Stavudine (d4T) Telbivudine (hepatitis B) Zidovudine (azidothymidine, or AZT)(HIV)

deoxyuridine analogues Idoxuridine Trifluridine

Nucleoside analogue drugs include:

Page 18: Antiviral therapy - General Principles
Page 19: Antiviral therapy - General Principles

Neuramidase release the assembled new influenza virus particles from cells

Neuramidase removed sialic acid

Page 20: Antiviral therapy - General Principles

Left: The enzyme is shown as strands. Relenza is space-filled. The single N-acetyl glucosamine residue on each chain of the dimer is shown as ball and stick. Right: The enzyme is space-filled showing the inhibitor at the active site in a cleft in the surface of the molecule.

Influenza virus neuraminidase complexed with Relenza

Page 21: Antiviral therapy - General Principles

Tamiflu-neuramidase inhibitor

Page 22: Antiviral therapy - General Principles

Zanamivir-neuramidase inhibitor

Page 23: Antiviral therapy - General Principles
Page 24: Antiviral therapy - General Principles

Interferon signaling

Frontiers in Bioscience 14, 4950-4961, 2009.

Page 25: Antiviral therapy - General Principles
Page 26: Antiviral therapy - General Principles
Page 27: Antiviral therapy - General Principles
Page 28: Antiviral therapy - General Principles

HIV life cycle

Page 29: Antiviral therapy - General Principles
Page 30: Antiviral therapy - General Principles
Page 31: Antiviral therapy - General Principles
Page 32: Antiviral therapy - General Principles
Page 33: Antiviral therapy - General Principles

, antisense RNA, and ribozymes

Page 34: Antiviral therapy - General Principles
Page 35: Antiviral therapy - General Principles
Page 36: Antiviral therapy - General Principles

QuestionsWhat antiviral drugs could be used to treat patients with HIV infection? please explain it, and put forward your idea how to design new drugs for anti-HIV infection.